首页> 外文期刊>Journal of pediatric gastroenterology and nutrition >Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome.
【24h】

Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome.

机译:粪便菌群移植在2例反复艰难梭菌感染儿童中的疗效及其对他们的生长和肠道微生物组的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Fecal microbiota transplantation (FMT) is recognized as an alternative therapeutic modality for recurrent Clostridium difficile infection (RCDI); however, data on its efficacy in children are lacking, including its effect on their growth and fecal microbiota. We report on 2 young children (<3 years old) who failed available therapeutics for RCDI, but responded remarkably well to FMT. Besides resolution of clinical features of C difficile infection (CDI), FMT administration led to marked improvement in their growth, along with increased microbiota diversity, especially proportion of Bacteroides. Our 2 cases illustrate the efficacy of FMT in children with RCDI and its positive effect on their growth and gut microbiota.
机译:粪便菌群移植(FMT)被认为是复发性艰难梭菌感染(RCDI)的另一种治疗方式。但是,尚缺乏有关其对儿童疗效的数据,包括其对儿童生长和粪便微生物群的影响。我们报告了2个年幼的儿童(<3岁),他们未能通过RCDI治疗,但对FMT的反应非常好。除了可以解决艰难梭菌感染(CDI)的临床特征外,FMT给药还可以显着改善其生长,并增加菌群多样性,尤其是拟杆菌的比例。我们的2例病例说明了FMT对RCDI儿童的疗效及其对他们的生长和肠道菌群的积极影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号